Neurostimulation devices are gaining acceptance as an alternative therapy for certain chronic pain conditions. These devices have also been used in the management of neurological disorders like Parkinson’s disease and epilepsy. The currently available neurostimulators mainly focus on SCS, deep brain stimulation (DBS), vagus nerve stimulation (VNS), and sacral nerve stimulation (SNS).

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 06: Market segmentation by application

PART 07: Market segmentation by product

Market overview

PART 08: Market segmentation by end-user

Market overview

Market size and forecast

PART 09: Geographical segmentation

SCS devices market in Americas

SCS devices market in EMEA

SCS devices market in APAC

PART 10: Market drivers

Rapid advances in high-frequency device technologies

leading to rise in implantation procedures

Favorable reimbursement and insurance approval

policies

High market potential for SCS devices in

neurostimulation

PART 11: Impact of drivers

PART 12: Market challenges

Stringent regulatory approvals and high cost of

devices

Availability of alternate effective medication options

Dearth of expertise and trained healthcare personnel

PART 13: Impact of drivers and challenges

PART 14: Market trends

Innovative techniques in minimally invasive spinal

surgery

Shift of surgeons' focus toward SCS procedures

Continuous investment by manufacturers

PART 15: Vendor landscape

Competitive scenario

PART 16: Key vendor analysis

Boston Scientific

Medtronic

Nevro

St. Jude Medical

Other prominent vendors

PART 17: Appendix

List of abbreviations

PART 18: Explore Technavio